CASP3 and neoplasm: This and our previous study demonstrated that NK3.3EVs kill tumor cells by apoptosis, as measured by increased frequencies of annexin V+ cells, increased caspase-3/7 activity, and cleavage of caspases-3, 7, and 9 [14,15].